Improvement in the moisture content of the stratum corneum following 4 weeks of collagen hydrolysate ingestion
This 2009 study examined whether oral collagen hydrolysate affected skin condition after four weeks in 214 healthy female volunteers. Its placebo-controlled, double-blind design compared three collagen hydrolysate doses, pig-skin collagen hydrolysate and placebo.The principal finding was increased moisture content of the cheek stratum corneum. Transepidermal water loss, skin viscoelasticity and cutaneous findings did not show statistically significant differences between groups.
What the study did and found
The researchers enrolled 214 healthy women with a mean age of 34.1 ± 5.9 years and randomly assigned them to five groups. Three groups received 2.5 g, 5 g or 10 g of collagen hydrolysate; another received 10 g of pig-skin collagen hydrolysate, and the control group received placebo. Skin measurements were taken before and after four weeks of ingestion.
Cheek stratum corneum moisture increased significantly within all hydrolysate groups, with a dose-dependent pattern across the 2.5–10 g series. In an analysis restricted to participants older than 30, the 5 g and 10 g groups differed significantly from placebo (P < 0.05). No statistically significant between-group differences were found for transepidermal water loss, viscoelasticity or cutaneous findings.
Why it is cited
The trial is an early controlled human investigation linking oral collagen hydrolysate intake to a measured skin hydration outcome. Its five-group design included a placebo comparator, three doses of one hydrolysate series and a separate pig-skin preparation.
Its results distinguish increased stratum corneum moisture from other skin characteristics that did not change significantly between groups. The dose-dependent trend is relevant, but it does not establish that each dose differed significantly from every other dose.
Placebo control, double blinding and random allocation support the study design. However, the publication details presented here do not establish the magnitude of the moisture change, the precision of its estimate or the number of participants completing each group. These uncertainties limit assessment of clinical importance. The clearest placebo comparison was reported for the 5 g and 10 g groups among women older than 30. Results from a four-week intervention in healthy women cannot establish long-term benefits, treatment effects in skin disease or comparable responses in other populations. |
The topic today
The study remains relevant to research on oral collagen peptides and skin hydration, particularly because it measured moisture alongside other skin properties. Its findings should not be generalized to improvements in skin elasticity, barrier function or visible ageing without separate supporting evidence.
Current interpretation requires attention to collagen preparation, dose, participant characteristics, measurement methods and follow-up duration. Later clinical trials may address these questions, but they should be evaluated independently rather than treated as confirmation of every outcome in the 2009 study.